Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2000
03/09/2000WO2000012532A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses
03/09/2000WO2000012531A1 Ratc
03/09/2000WO2000012530A1 dU SITE-DIRECTED CLEAVAGE OF COVALENT CONJUGATES
03/09/2000WO2000012527A1 Antisense modulation of tradd expression
03/09/2000WO2000012525A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000WO2000012524A1 Purification of oligomers using dual-end selection
03/09/2000WO2000012191A1 Fraction collection system and method
03/09/2000WO2000012175A2 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
03/09/2000WO2000012140A1 Method for labeling biopolymers using isotopes
03/09/2000WO2000012139A1 Hypoxia regulated genes
03/09/2000WO2000012138A2 Cells expressing immunoregulatory molecules and uses therefor
03/09/2000WO2000012133A1 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012131A1 Multicomponent vaccines
03/09/2000WO2000012123A2 Method and measuring device for determining a plurality of analytes in a sample
03/09/2000WO2000012120A1 A pharmaceutical composition containing calcineurin b subunit
03/09/2000WO2000012116A1 Method for administering insulinotropic peptides
03/09/2000WO2000012114A1 Peptide scaffolds for transfer of molecules into eukaryotic cells
03/09/2000WO2000012111A2 Selective treatment of endothelial somatostatin receptors
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a
03/09/2000WO2000001829A3 Formaldehyde dehydrogenase genes from methylotrophic yeasts
03/09/2000WO2000001796A3 Starch debranching enzymes
03/09/2000WO2000000607B1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid
03/09/2000WO1999067402A3 Methods to screen herbicidal compounds utilizing air synthetase from arabidopsis thaliana
03/09/2000WO1999067389A3 Cryptic regulatory elements obtained from plants
03/09/2000WO1999067291A3 Site specific protein modification by mutagenesis
03/09/2000WO1999065515A3 Combination of radiotherapy and anti-angiogenic factors
03/09/2000WO1999064616A3 Polyunsaturated fatty acids in plants
03/09/2000WO1999064570A9 Novel methods and interferon deficient substrates for the propagation of viruses
03/09/2000WO1999064068A9 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
03/09/2000WO1999063078A9 Retinal calcium channel (alpha)1f-subunit gene
03/09/2000WO1999063055A9 Genes of carotenoid biosynthesis and metabolism and methods of use thereof
03/09/2000WO1999062592A9 Flow-through electroporation system for ex vivo gene therapy
03/09/2000WO1999062333A9 Bacteriophage-based transgenic fish for mutation detection
03/09/2000WO1999061590A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
03/09/2000WO1999061580A3 Modification of cereal grain hardness via expression of puroindoline proteins
03/09/2000WO1999060017A3 Human tumour-derived polypeptide hormone phosphatonin
03/09/2000WO1999060013A3 Il-6 antagonist peptides
03/09/2000WO1999058686A3 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b12 transport
03/09/2000WO1999058671A9 Human and nematode homologues of the yeast longevity assurance gene lag1
03/09/2000WO1999058654A3 Transgenic plants with a modified activity of a plastidial adp/atp translocator
03/09/2000WO1999058653A3 Method for producing plants having an increased tolerance against drought and/or fungal attack and/or increased salt concentrations and/or extreme temperature by the expression of plasmodesmata-localized proteins
03/09/2000WO1999055883A3 Triacylglycerol lipases
03/09/2000WO1999055873A3 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
03/09/2000WO1999053070A9 Flowering locus t (ft) and genetically modified plants having modulated flower development
03/09/2000WO1999050415A3 Protease-activated receptor par4 (zchemr2)
03/09/2000WO1999045105A3 Highly crystalline urokinase
03/09/2000WO1999043791A3 Diisopropyl fluorophosphatase and the utilization and production thereof
03/09/2000DE4090565C2 Rekombinantes Herpesvirus-Pockenvirus-Vakzin A recombinant herpesvirus poxvirus vaccine
03/09/2000DE19845277C1 Wolframin, a transmembrane protein and related DNA useful for diagnosis and therapy of Wolfram Syndrome, especially where there is a tendency to psychiatric disease
03/09/2000DE19845251A1 Peptide für Pharmatargeting Peptides for drug targeting
03/09/2000DE19840731A1 Zwei Farben Differential Display als Verfahren zur Detektion regulierter Gene Two colors as differential display method for detecting regulated genes
03/09/2000DE19840531A1 Mit Nukleinsäuren beschichtete Reaktionsräume, Verfahren zu ihrer Herstellung und ihre Verwendung Coated with nucleic acids reaction chambers, process for their preparation and their use
03/09/2000DE19840028A1 Nucleinsäuremoleküle codierend Enzyme, die Fructosyltransferaseaktivität besitzen, und deren Verwendung Nucleic acid molecules encoding enzymes having fructosyltransferase activity which, and their use
03/09/2000DE19839567A1 Organismen zur extrazellulären Herstellung von Riboflavin Organisms for the extracellular production of riboflavin
03/09/2000DE19839115A1 Klonierung und Expression von Rinder Estrogenrezeptor-beta Cloning and expression of bovine estrogen receptor-beta
03/09/2000CA2777661A1 Multicomponent vaccines
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2344591A1 Methods for improving the function of heterologous g protein-coupled receptors
03/09/2000CA2343046A1 Enhanced functional expression of g protein-coupled receptors
03/09/2000CA2342581A1 Reaction chambers coated with defined concentrations of nucleic acids, method for the production and use thereof
03/09/2000CA2342534A1 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000CA2342205A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000CA2341896A1 Support for a method for determining an analyte and a method for producing the support
03/09/2000CA2341894A1 Method and device for preparing and/or analyzing biochemical reaction carriers
03/09/2000CA2341775A1 Inducible expression system
03/09/2000CA2341766A1 Mammalian elk potassium channel genes
03/09/2000CA2341761A1 Novel polypeptide
03/09/2000CA2341755A1 Cells expressing immunoregulatory molecules and uses therefor
03/09/2000CA2341715A1 Organisms for the extracellular production of riboflavin
03/09/2000CA2341705A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000CA2341687A1 Self-contained device integrating nucleic acid extraction, amplification and detection
03/09/2000CA2341639A1 Superoxide dismutase as a vaccine antigen
03/09/2000CA2341627A1 Method for assessing the relative purity of viral gene transfer vector stocks
03/09/2000CA2341518A1 Hypoxia regulated genes
03/09/2000CA2341454A1 Method for administering insulinotropic peptides
03/09/2000CA2341412A1 Rationally designed heparinases derived from heparinase i and ii
03/09/2000CA2341324A1 Transgene assay using stable agrobacterium rhizogenes transformation
03/09/2000CA2341312A1 Maize ku70 orthologue and uses thereof
03/09/2000CA2341311A1 Staphylococcus aureus genes and polypeptides
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2341148A1 Human membrane channel proteins
03/09/2000CA2341142A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers
03/09/2000CA2341064A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000CA2341051A1 Cell specific promoters of uncoupling protein 3
03/09/2000CA2340937A1 A new method of identifying non-host plant disease resistance genes
03/09/2000CA2340865A1 High-affinity antibodies
03/09/2000CA2340796A1 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
03/09/2000CA2340794A1 Protein transport-associated molecules
03/09/2000CA2340617A1 Genes associated with neurotransmitter processing
03/09/2000CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000CA2340594A1 Method for remodelling an animal genome by zygotic transfer of a site-specific recombinase
03/09/2000CA2340592A1 Phelix: a testis-specific protein expressed in cancer
03/09/2000CA2340589A1 Toxicological response markers
03/09/2000CA2340579A1 Interleukin 18-binding protein
03/09/2000CA2340462A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000CA2340276A1 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
03/09/2000CA2339087A1 Modification of plant fibres
03/09/2000CA2339043A1 Further pro polypeptides and sequences thereof
1 ... 3274 3275 3276 3277 3278 3279 3280 3281 3282 3283 3284 3285 3286 3287 3288 3289 3290 3291 3292 3293 3294 ... 4023